(IN BRIEF) AstraZeneca's new drug application (NDA) for capivasertib, in combination with Faslodex, has been accepted and granted Priority Review…
PARIS, 16-7-2015 — /EuropaWire/ — Today (July 15, 2015), NuGeneration Ltd (NuGen), owned 60% by Toshiba and 40% by ENGIE,…
London, UK, 23-10-2013 — /EuropaWire/ — GlaxoSmithKline plc (LSE:GSK) today announced the submission of a New Drug Application (NDA) in the US…